Worth reading
29Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Earnings presentationFiscal year ending March 20264 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥9,771 million+2.1%
Operating profit¥2,130 million+9.1%
Ordinary income¥2,206 million+7.3%
Net income¥1,549 million-0.7%
Gross Profit Margin33 %
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Decline following the reaction to demand for capital investment in India
- Lower production volumes due to the switch to certain products
- Higher production volumes of blood pressure monitor cuffs
- Higher production of blood pressure monitor cuffs and car seats
- Increased staffing and wage increases
- New-product development costs in the Medical Healthcare business
The company identifies the factors but does not state the amount attributable to each one.
New initiatives
- Construction of the Honai No. 2 Plant in Vietnam (site area: 12,000 sq. m.; planned investment: ¥600 million to ¥800 million; completion scheduled for September 2026; production scheduled to begin in April 2027)
- Use of the INNOVATION PLANT in Ono, Fukui Prefecture (expansion of production space and development base for the automated sewing machinery business)
- Automation of blood pressure monitor cuff production processes and a review of the supply chain
- Strengthening the rehabilitation robot business and introducing new products
- Expansion into new business areas, including wearable devices
- Development of automated production lines using 3D sewing robots and AI-based visual inspection equipment
- Development of airbags for drones
- Accelerating the development of next-generation automated sewing machinery through business alliances
Segment results
Medical and healthcare business
Net Sales
¥6,808 million+12.4%
Segment profit
¥2,124 million+6.9%
Safety systems business
Net Sales
¥2,861 million-15.3%
Segment profit
¥397 million+57.3%
Other
Net Sales
¥101 million-21.2%
Segment profit
¥-35 million
Capital expenditures
¥620 million
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Net Sales | ¥9,771 million (YoY +2.1%) |
| Operating profit | ¥2,130 million (YoY +9.1%) |
| Ordinary income | ¥2,206 million (YoY +7.3%) |
| Net income | ¥1,549 million (YoY -0.7%) |
| Gross Profit Margin | 33 % |
| Segment results | Medical and healthcare business Net Sales ¥6,808 million (YoY +12.4%) / Segment profit ¥2,124 million (YoY +6.9%) / Safety systems business Net Sales ¥2,861 million (YoY -15.3%) / Segment profit ¥397 million (YoY +57.3%) / Other Net Sales ¥101 million (YoY -21.2%) / Segment profit ¥-35 million |
| Breakdown of Factors Affecting the Change | Factors Decline following the reaction to demand for capital investment in India / Amount Not disclosed, Factors Lower production volumes due to the switch to certain products / Amount Not disclosed, Factors Higher production volumes of blood pressure monitor cuffs / Amount Not disclosed, Factors Higher production of blood pressure monitor cuffs and car seats / Amount Not disclosed, Factors Increased staffing and wage increases / Amount Not disclosed, Factors New-product development costs in the Medical Healthcare business / Amount Not disclosed |
| Capital expenditures | ¥620 million |
| New initiatives | Construction of the Honai No. 2 Plant in Vietnam (site area: 12,000 sq. m.; planned investment: ¥600 million to ¥800 million; completion scheduled for September 2026; production scheduled to begin in April 2027), Use of the INNOVATION PLANT in Ono, Fukui Prefecture (expansion of production space and development base for the automated sewing machinery business), Automation of blood pressure monitor cuff production processes and a review of the supply chain, Strengthening the rehabilitation robot business and introducing new products, Expansion into new business areas, including wearable devices, Development of automated production lines using 3D sewing robots and AI-based visual inspection equipment, Development of airbags for drones, Accelerating the development of next-generation automated sewing machinery through business alliances |
Items this document does not state (20)
Operating profit marginSelling, general and administrative expensesResults for the three months of the current quarterFull-year earnings forecastProgress against full-year forecastSelf-assessment against the planKey KPIsUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Gross profit, operating profit and ordinary profit increased as a result of higher sales and production of blood pressure monitor cuffs, increased car-seat production and steady performance at the Vietnam production facility. The Company stated that operating profit absorbed the impact of higher personnel expenses due to increased staffing and wage increases, as well as higher new-product development costs in the Medical Healthcare business. The reason for not presenting an earnings forecast for the fiscal year ending March 2027 is that the Company is expected to be delisted following the tender offer and subsequent procedures.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.